Enanta Pharmaceuticals, Inc. (ENTA) vs Orchestra BioMed Holdings, Inc. (OBIO)
- Enanta Pharmaceuticals, Inc. ENTA 11.10 −3.23%
- Orchestra BioMed Holdings, Inc. OBIO 5.45 −5.05%
Enanta Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($345.0M and $334.1M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 0.70%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −186.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Enanta Pharmaceuticals, Inc. leads on 11 and Orchestra BioMed Holdings, Inc. on 5.
Valuation
Profitability
| Metric | ENTA | OBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.51% | 65.16% |
| Operating margin | (89.99%) | (181.36%) | 0.00% |
| Net margin | (96.89%) | (186.30%) | 0.00% |
| Free cash flow margin | (56.60%) | (184.83%) | 0.00% |
| Return on equity | (70.12%) | (607.32%) | (56.36%) |
| Return on assets | (21.15%) | (75.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack